Skip to content
2000
Volume 4, Issue 1
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

The interaction between the chemokine, CXCL12 and its receptor, CXCR4 is known to be involved in several intractable disease processes, including HIV infection, cancer cell metastasis, leukemia cell progression and rheumatoid arthritis. It is conjectured that this interaction may be an important therapeutic target in all of these diseases, and various CXCR4 antagonists have been proposed as potential drugs. This article describes the development in our laboratory of a number of specific CXCR4 antagonists.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/157018007778992900
2007-01-01
2025-05-29
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/157018007778992900
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test